Indeed, both LRP5 and LRP6 receptors are downregulated upon TRAP1 interference and this correlates with the inhibition of Wnt/β-Catenin pathway and loss of sphere formation in patients-derived CRC CSCs. The gene discussed is LRP5; the disease is colorectal carcinoma.